http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-9711081-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5bc5292a07e34d16eb1d033a16d3aec3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_25075351c1dbea503efe80e53c0e11bb
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6425
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2896
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-70596
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-705
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127
filingDate 1997-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b6c57969b40aa7504c664426f2fa1bf8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4a5856d750ad4de5fae81ed838103ef5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fd02fd132cbcc7d6c38bc03cccc5c675
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e7c0b3240a1550a5cdc4d5beb49afcf9
publicationDate 2000-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber BR-9711081-A
titleOfInvention Targeting of macromolecular prodrugs to t lymphocytes.
abstract Invention Patent: <B> "DIRECTION OF PRO - MACROMOLECULAR DRUGS FOR T LYMPHOCYTES" <D>. Composition for intracellular release of a chemical agent to a T cell, comprising a receptor binding and endocytosis-inducing ligand and a chemical agent coupled to a water-soluble polymer. The ligand binds to a receptor on T lymphocytes causes the composition's endositosis. The composition also includes a spacer for coupling the chemical and binding agent to the polymer. Chemical agents can include cytotoxins, transforming nucleic acids, gene regulators, markers, antigens, drugs and others. A preferred water-soluble polymer is a copolymer of N- (2 - hydroxypropyl) methacrylamide (HPMA). The composition can also comprise a carrier, such as a water-soluble polymer, liposome or particles. Methods for using these compositions for the delivery of a chemical agent in vivo or in vitro are also presented.
priorityDate 1996-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422086911
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID38622

Total number of triples: 27.